
Godavari BiorefineriesQ4 FY25
Godavari Biorefineries Q4 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹202.97P/E: 36.0Market Cap: ₹1.0K Cr
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 2- Godavari Biorefineries targets a 3x increase in EBITDA by FY29, driven by growth in ethanol and bio-based specialty chemicals.
- Ethanol segment growth supported by commissioning of 200-kiloliter/day grain/maize-based distillery in Q4 FY26, adding multi-feedstock capacity.
- Continued de-bottlenecking and capacity expansions planned for bio-based chemical segment to meet rising demand.
- Bio-based chemicals EBITDA more than doubled in FY25, indicating strong growth momentum.
- Strategic diversification into bio-butanol and higher alcohols (licensed technology) expected to boost revenues over next few years.
- Expansion plans include increased ethanol production from B heavy molasses, sugarcane juice/syrup, and new feedstocks like grain and maize.
- Long-term growth driven by co-creation with customers focused on green chemicals and energy transition.
- Expect revenue and margin expansion progress to become evident progressively through FY27-29.
See what Godavari Biorefineries management said on margin guidance — free account, 30 seconds.
Fundraise plans
- There is no specific mention of any current or planned fundraising through debt or equity in the transcript.
- The company has strengthened its financial position by reducing debt, which has lowered its interest burden and created headroom for future expansion and strategic investments.
- Capex plans for FY26 include approximately INR130 crores for the grain-based ethanol facility and investments in debottlenecking bio-based chemicals and biobutanol projects.
- The company is working on detailed engineering packages for expansion but has not provided firm capital expenditure figures or fundraising requirements yet.
- Any further clarity on capital expenditure and potential funding needs will be shared in future updates or board meetings.
See what Godavari Biorefineries management said on order book — free account, 30 seconds.
Capex plans
Yes- Godavari Biorefineries is investing in a grain/maize-based ethanol facility with a capacity of 200,000 liters per day, expected to be commissioned in Q4 FY26, with an estimated capex of INR 130 crores (net of GST).
- The company is undertaking debottlenecking initiatives to optimize bio-based specialty chemical production capacity, supporting growth in this segment.
- Engineering work is underway for a biobutanol project licensed from Catalyxx, which will expand their sustainable chemistry portfolio; detailed engineering design is in progress.
- Continuous maintenance capex is also planned annually as part of regular operations.
- Overall capex will support achieving a targeted 3x EBITDA growth by FY29, driven by expansions in both ethanol and specialty chemical segments.
Track Godavari Biorefineries — get its next earnings analysis in your feed
How does Godavari Biorefineries rank vs peers in ?
Pro featureThisGodavari Biorefineries
Rev 2Mar 3